美国 · 平台与数据 · MarketBeat
Anika Therapeutics' (ANIK) "Buy" Rating Reiterated at B. Riley Financial

详细摘要
B. Riley Financial reissued a "buy" rating and set a $17.00 price objective (down from $23.00) on shares of Anika Therapeutics in a research note on Monday.
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.marketbeat.com)



